The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

Nature

Volumn 462, Issue 7275, 2009, Pages 886-890

  Morris, Joanna R ^a   Boutell, Chris ^b   Keppler, Melanie ^c   Densham, Ruth ^a   Weekes, Daniel ^a   Alamshah, Amin ^a   Butler, Laura ^a   Galanty, Yaron ^d   Pangon, Laurent ^a   Kiuchi, Tai ^c   Ng, Tony ^c   Solomon, Ellen ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF VIROLOGY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEIN INHIBITOR OF ACTIVATED STAT; SUMO 1 PROTEIN; SUMO 2 PROTEIN; UBIQUITIN PROTEIN LIGASE E3;

AMINO ACID; BIOACCUMULATION; CANCER; DNA; ENZYME ACTIVITY; GENOTOXICITY; HEALTH RISK; MAMMAL; MUTATION; PROTEIN;

ARTICLE; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; GENOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; SUMOYLATION;

ANIMALS; BRCA1 PROTEIN; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; HELA CELLS; HISTONES; HUMANS; PROTEIN INHIBITORS OF ACTIVATED STAT; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

MAMMALIA;

EID: 72449163470     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08593     Document Type: Article

References (50)

1. Lorick, K. L. et al. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl Acad. Sci. USA 96, 11364-11369 (1999).
2. Hashizume, R. et al. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 276, 14537-14540 (2001).
3. Brzovic, P. S. et al. Binding and recognition in the assembly of an active BRCA1/ BARD1 ubiquitin-ligase complex. Proc. Natl Acad. Sci. USA 100, 5646-5651 (2003).
4. Morris, J. R. et al. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum. Mol. Genet. 15, 599-606 (2006).
5. Morris, J. R. & Solomon, E. BRCA1: BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum. Mol. Genet. 13, 807-817 (2004).
6. Morris, J. R. & Solomon, E. in The Role of Genetics in Breast and Reproductive Cancers (ed. Welcsh, P. L.) 75-92 (Springer Science1Business Media and Humana Press, 2009).
7. Reid, L. J. et al. E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc. Natl Acad. Sci. USA 105, 20876-20881 (2008).
8. Polanowska, J., Martin, J. S., Garcia-Muse, T., Petalcorin, M. I. & Boulton, S. J. A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J. 25, 2178-2188 (2006).
9. Zhao, G. Y. et al. A critical role for the ubiquitin-conjugating enzyme Ubc13 in initiating homologous recombination. Mol. Cell 25, 663-675 (2007).
10. Doil, C. et al. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 136, 435-446 (2009).
11. Huen, M. S. et al. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 131, 901-914 (2007).
12. Kolas, N. K. et al. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 318, 1637-1640 (2007).
13. Mailand, N. et al. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 131, 887-900 (2007).
14. Wang, B. & Elledge, S. J. Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage. Proc. Natl Acad. Sci. USA 104, 20759-20763 (2007).
15. Kim, H., Huang, J. & Chen, J. CCDC98 is a BRCA1-BRCT domain-binding protein involved in the DNA damage response. Nature Struct. Mol. Biol. 14, 710-715 (2007). (Pubitemid 47220062)
16. Kim, H., Chen, J. & Yu, X. Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response. Science 316, 1202-1205 (2007). (Pubitemid 46877484)
17. Liu, Z., Wu, J. & Yu, X. CCDC98 targets BRCA1 to DNA damage sites. Nature Struct. Mol. Biol. 14, 716-720 (2007).
18. Sobhian, B. et al. RAP80 targets BRCA1 to specific ubiquitin structures at DNA damage sites. Science 316, 1198-1202 (2007).
19. Wang, B. et al. Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response. Science 316, 1194-1198 (2007).
20. Yan, J. et al. The ubiquitin-interacting motif containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response. Cancer Res. 67, 6647-6656 (2007).
21. Stewart, G. S. et al. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136, 420-434 (2009).
22. Hay, R. T. SUMO: a history of modification. Mol. Cell 18, 1-12 (2005).
23. Mo, Y. Y., Yu, Y., Ee, P. L. & Beck, W. T. Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res. 64, 2793-2798 (2004).
24. Zhao, X. & Blobel, G. A. SUMO ligase is part of a nuclear multiprotein complex that affects DNA repair and chromosomal organization. Proc. Natl Acad. Sci. USA 102, 4777-4782 (2005).
25. Potts, P. R. & Yu, H. Human MMS21/NSE2 is a SUMO ligase required for DNA repair. Mol. Cell. Biol. 25, 7021-7032 (2005).
26. Mabb, A. M., Wuerzberger-Davis, S. M. & Miyamoto, S. PIASy mediates NEMO sumoylation and NF-kB activation in response to genotoxic stress. Nature Cell Biol. 8, 986-993 (2006).
27. Ishiai, M. et al. DNA cross-link repair protein SNM1A interacts with PIAS1 in nuclear focus formation. Mol. Cell. Biol. 24, 10733-10741 (2004).
28. Boulton, S. J. et al. BRCA1/BARD1 orthologs required for DNA repair in Caenorhabditis elegans. Curr. Biol. 14, 33-39 (2004).
29. Park, M. A., Seok, Y. J., Jeong, G. & Lee, J. S. SUMO1 negatively regulates BRCA1-mediated transcription, via modulation of promoter occupancy. Nucleic Acids Res. 36, 263-283 (2008).
30. Peter, M. & Ameer-Beg, S. M. Imaging molecular interactions by multiphoton FLIM. Biol. Cell 96, 231-236 (2004).
31. Peter, M. et al. Multiphoton-FLIM quantification of the EGFP-mRFP1 FRET pair for localization of membrane receptor-kinase interactions. Biophys. J. 88, 1224-1237 (2005).
32. Ng, T. et al. Imaging protein kinase Ca activation in cells. Science 283, 2085-2089 (1999).
33. Ganesan, S., Ameer-Beg, S. M., Ng, T. T., Vojnovic, B. & Wouters, F. S. A dark yellow fluorescent protein (YFP)-based resonance energy-accepting chromoprotein (REACh) for Forster resonance energy transfer with GFP. Proc. Natl Acad. Sci. USA 103, 4089-4094 (2006).
34. Dadke, S. et al. Regulation of protein tyrosine phosphatase 1B by sumoylation. Nature Cell Biol. 9, 80-85 (2007).
35. Bossis, G. & Melchior, F. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. Mol. Cell 21, 349-357 (2006).
36. Schmidt, D. & Muller, S. PIAS/SUMO: new partners in transcriptional regulation. Cell. Mol. Life Sci. 60, 2561-2574 (2003).
37. Munarriz, E. et al. PIAS-1 is a checkpoint regulator which affects exit from G1 and G2 by sumoylation of p73. Mol. Cell. Biol. 24, 10593-10610 (2004).
38. Kim, H. & Chen, J. New players in the BRCA1-mediated DNA damage responsive pathway. Mol. Cells 25, 457-461 (2008).
39. Nishikawa, H., Ooka, S., Sato, K., Arima, K., Okamoto, J., Klevit, R. E., Fukuda, M. & Ohta, T. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase. J Biol Chem, (2003).
40. Wu-Baer, F., Lagrazon, K., Yuan, W. & Baer, R. The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitin. J. Biol. Chem. 278, 34743-34746 (2003).
41. Mallery, D. L.,Vandenberg, C. J. & Hiom, K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J. 21, 6755-6762 (2002).
42. Christensen, D. E., Brzovic, P. S. & Klevit, R. E. E2-BRCA1 RING interactions dictate synthesis of mono-or specific polyubiquitin chain linkages. Nature Struct. Mol. Biol. 14, 941-948 (2007).
43. Manke, I. A., Lowery, D. M., Nguyen, A. & Yaffe, M. B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302, 636-639 (2003).
44. Jaffray, E. G. & Hay, R. T. Detection of modification by ubiquitin-like proteins. Methods 38, 35-38 (2006).
45. Prag, S. et al. Activated ezrin promotes cell migration through recruitment of the GEF Dbl to lipid rafts and preferential downstream activation of Cdc42. Mol. Biol. Cell 18, 2935-2948 (2007).
46. Barber, P. R., Ameer-Beg, S. M., Gilbey, J. D., Edens, R. J., Ezike, I. & Vojnovic, B. Global and pixel kinetic data analysis for FRET detection by multi-photon time-domain FLIM. Proc. SPIE 5700, 171-181 (2005).
47. Bennardo, N., Cheng, A., Huang, N. & Stark, J. M. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 4, e1000110 (2008).
48. Boutell, C., Orr, A. & Everett, R. D. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0. J. Virol. 77, 8686-8694 (2003).
49. Boutell, C., Sadis, S. & Everett, R. D. Herpes simplex virus type 1 immediate-early protein ICP0 and its isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76, 841-850 (2002).
50. Bliss, C. I. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26, 585-615 (1939).